The concept of chronic microbial infections, and more specifically the term biofilm, initially entered the scientific and microbiological world in relation to dental biofilms such as plaque. Plaque is the most well-known and researched area of biofilm research with well understood causes and consequences. Biofilm removal techniques and products have also undergone a large amount of research within the dental world with physical removal such as teeth brushing and dental floss being combined with biofilm disruption agents in toothpastes and mouthwashes.
Despite the high body of knowledge in this area there is still a lot of research and development required in the dental industry. This includes the development of products that disrupt and remove oral biofilms and anti-microbial products that can be used to prevent and remove biofilm material and chronic microbial buildup in dental waterlines and on dental surfaces equipment.
Our testing experience includes working with:
- Mouth washes
- Dental unit water lines
- Antimicrobial peptides
We offer a range of test methodologies which include:
- Single species oral biofilm assays
- Multi-species oral biofilm assays
- ISO 16954: Test methods for dental unit waterline biofilm treatment
Our library of test organism includes…
Choose from our library of test organism including standard reference strains, clinical isolates and environmental isolates.
Single or mixed species assays containing:
Acinetobacter baumannii, Actinomyces naeslundii, Adenovirus (human), Aspergillus brasiliensis, Aspergillums niger, Aureobasidium pullulans, Bacillus cereus, Bacillus subtilis, Camplylobacter jejuni, Candida albicans, Clostridium difficile, Corynebacterium minutissimum, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium (VRE), Enterococcus hirae, Escherichia coli, Fusobacterium nucleatum, Haemophilus influenzae, Heliocbacter pylori, Halomonas magadiensis, Klebsiella pneumoniae, Lactobacillus casei, MRSA, Neisseria gonorrhoeae, Neisseria subflava, Porphyromonas ginigvalis, Prevotella nigrescens, Propionibacterium acnes, Proteus mirabilis, Pseudomonas aeruginosa, Salmonella enteritidis, Shigella dysenteriae, Staphylococcus aureus (MRSA and MSSA), Staphylococcus epidermidis, Staphylococcus haemolyticus, Stenotrophomonas maltophilia, Streptococcus mutans, Streptococcus oralis, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus zooepidemicus, Tannerella forsythia, Trichophyton rubrum, Veillonella dispar. WHO Priority organisms. Other- please ask.
- Christmas Opening Hours
- Regulatory Focus; Medical Device Regulations
- World Health Organisation publishes list of bacteria for which new antibiotics are needed
- Perfectus Biomed shortlisted for the Mornflake Oats Award for Innovation and the Outstanding Cheshire & Warrington Business Leader Award
- FDA to improve the review of shared Risk Evaluation and Mitigation Strategies to enhance generic drug access
- The National Biofilms Innovation Centre (NBIC) Launch Event
- Perfectus Biomed Website Redesign
- EPA protects health care facilities from unregistered antimicrobial pesticides
- Living Wage Week
- Pharmig’s 25th Celebratory Conference 2017